INVITAE CORP (NVTA) Fundamental Analysis & Valuation

NYSE:NVTA • US46185L1035

0.0891 USD
-0.3 (-77.12%)
Last: Feb 5, 2024, 07:40 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This NVTA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

Taking everything into account, NVTA scores 2 out of 10 in our fundamental rating. NVTA was compared to 101 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of NVTA have multiple concerns. NVTA is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. NVTA Profitability Analysis

1.1 Basic Checks

  • NVTA had negative earnings in the past year.
  • In the past year NVTA has reported a negative cash flow from operations.
NVTA Yearly Net Income VS EBIT VS OCF VS FCFNVTA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 -1B -2B -3B

1.2 Ratios

  • With a Return On Assets value of -269.22%, NVTA is not doing good in the industry: 96.49% of the companies in the same industry are doing better.
  • Looking at the Return On Invested Capital, with a value of 381.98%, NVTA belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
ROA -269.22%
ROE N/A
ROIC 381.98%
ROA(3y)-61.41%
ROA(5y)-52.18%
ROE(3y)-1031.52%
ROE(5y)-647.66%
ROIC(3y)N/A
ROIC(5y)N/A
NVTA Yearly ROA, ROE, ROICNVTA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 -1K -2K -3K

1.3 Margins

  • With an excellent Operating Margin value of 378.20%, NVTA belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • NVTA has a Gross Margin (27.14%) which is in line with its industry peers.
  • NVTA's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 378.2%
PM (TTM) N/A
GM 27.14%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-21.59%
GM growth 5Y-3.73%
NVTA Yearly Profit, Operating, Gross MarginsNVTA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 0 -200 -400 -600

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. NVTA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), NVTA is creating value.
  • The number of shares outstanding for NVTA has been increased compared to 1 year ago.
  • Compared to 1 year ago, NVTA has a worse debt to assets ratio.
NVTA Yearly Shares OutstandingNVTA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M 200M
NVTA Yearly Total Debt VS Total AssetsNVTA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 1B 2B 3B 4B

2.2 Solvency

  • Based on the Altman-Z score of -3.51, we must say that NVTA is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of NVTA (-3.51) is worse than 86.84% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -3.51
ROIC/WACC172.06
WACC2.22%
NVTA Yearly LT Debt VS Equity VS FCFNVTA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 1B 2B

2.3 Liquidity

  • NVTA has a Current Ratio of 2.39. This indicates that NVTA is financially healthy and has no problem in meeting its short term obligations.
  • NVTA's Current ratio of 2.39 is fine compared to the rest of the industry. NVTA outperforms 79.82% of its industry peers.
  • NVTA has a Quick Ratio of 2.25. This indicates that NVTA is financially healthy and has no problem in meeting its short term obligations.
  • NVTA's Quick ratio of 2.25 is fine compared to the rest of the industry. NVTA outperforms 78.95% of its industry peers.
Industry RankSector Rank
Current Ratio 2.39
Quick Ratio 2.25
NVTA Yearly Current Assets VS Current LiabilitesNVTA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. NVTA Growth Analysis

3.1 Past

  • NVTA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 58.74%, which is quite impressive.
  • The Revenue has decreased by -7.37% in the past year.
  • NVTA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 49.91% yearly.
EPS 1Y (TTM)58.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.19%
Revenue 1Y (TTM)-7.37%
Revenue growth 3Y33.54%
Revenue growth 5Y49.91%
Sales Q2Q%-9.21%

3.2 Future

  • Based on estimates for the next years, NVTA will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.71% on average per year.
  • The Revenue is expected to grow by 3.73% on average over the next years.
EPS Next Y53.25%
EPS Next 2Y26.21%
EPS Next 3Y18.34%
EPS Next 5Y12.71%
Revenue Next Year-6.03%
Revenue Next 2Y0.81%
Revenue Next 3Y3.75%
Revenue Next 5Y3.73%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
NVTA Yearly Revenue VS EstimatesNVTA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M
NVTA Yearly EPS VS EstimatesNVTA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 -1 -2 -3

More info and screens

Find the best growth stocksShow best growing peers

1

4. NVTA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for NVTA. In the last year negative earnings were reported.
  • Also next year NVTA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NVTA Price Earnings VS Forward Price EarningsNVTA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, NVTA is valued cheaply inside the industry as 98.25% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 0.53
NVTA Per share dataNVTA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 -2 -3

4.3 Compensation for Growth

  • NVTA's earnings are expected to grow with 18.34% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.21%
EPS Next 3Y18.34%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. NVTA Dividend Analysis

5.1 Amount

  • No dividends for NVTA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

NVTA Fundamentals: All Metrics, Ratios and Statistics

INVITAE CORP

NYSE:NVTA (2/5/2024, 7:40:05 PM)

0.0891

-0.3 (-77.12%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-08
Earnings (Next)02-21
Inst Owners0.08%
Inst Owner Change0%
Ins Owners3.24%
Ins Owner Change0%
Market Cap25.53M
Revenue(TTM)481.60M
Net Income(TTM)-1.44B
Analysts46.15
Price Target0.72 (708.08%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)44.39%
Min EPS beat(2)19.77%
Max EPS beat(2)69%
EPS beat(4)4
Avg EPS beat(4)33.24%
Min EPS beat(4)7.42%
Max EPS beat(4)69%
EPS beat(8)6
Avg EPS beat(8)21.36%
EPS beat(12)6
Avg EPS beat(12)8.33%
EPS beat(16)9
Avg EPS beat(16)6.63%
Revenue beat(2)0
Avg Revenue beat(2)-1.81%
Min Revenue beat(2)-1.89%
Max Revenue beat(2)-1.72%
Revenue beat(4)0
Avg Revenue beat(4)-1.47%
Min Revenue beat(4)-1.89%
Max Revenue beat(4)-0.98%
Revenue beat(8)0
Avg Revenue beat(8)-2.01%
Revenue beat(12)3
Avg Revenue beat(12)-1.95%
Revenue beat(16)6
Avg Revenue beat(16)0.31%
PT rev (1m)-45.8%
PT rev (3m)-52.03%
EPS NQ rev (1m)-14.83%
EPS NQ rev (3m)-8.11%
EPS NY rev (1m)0%
EPS NY rev (3m)20.44%
Revenue NQ rev (1m)-6.28%
Revenue NQ rev (3m)-6.48%
Revenue NY rev (1m)-0.16%
Revenue NY rev (3m)-0.48%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.05
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 0.53
EPS(TTM)-1.11
EYN/A
EPS(NY)-0.9
Fwd EYN/A
FCF(TTM)-0.87
FCFYN/A
OCF(TTM)-0.83
OCFYN/A
SpS1.68
BVpS-3.78
TBVpS-3.78
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -269.22%
ROE N/A
ROCE 483.52%
ROIC 381.98%
ROICexc 1178.47%
ROICexgc 1178.47%
OM 378.2%
PM (TTM) N/A
GM 27.14%
FCFM N/A
ROA(3y)-61.41%
ROA(5y)-52.18%
ROE(3y)-1031.52%
ROE(5y)-647.66%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-21.59%
GM growth 5Y-3.73%
F-Score3
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 0.68
Cap/Depr 6.96%
Cap/Sales 1.99%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.39
Quick Ratio 2.25
Altman-Z -3.51
F-Score3
WACC2.22%
ROIC/WACC172.06
Cap/Depr(3y)54.7%
Cap/Depr(5y)66.37%
Cap/Sales(3y)10.13%
Cap/Sales(5y)8.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)58.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.19%
EPS Next Y53.25%
EPS Next 2Y26.21%
EPS Next 3Y18.34%
EPS Next 5Y12.71%
Revenue 1Y (TTM)-7.37%
Revenue growth 3Y33.54%
Revenue growth 5Y49.91%
Sales Q2Q%-9.21%
Revenue Next Year-6.03%
Revenue Next 2Y0.81%
Revenue Next 3Y3.75%
Revenue Next 5Y3.73%
EBIT growth 1Y329.11%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year65.63%
EBIT Next 3Y20.35%
EBIT Next 5Y16.33%
FCF growth 1Y54.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y52.11%
OCF growth 3YN/A
OCF growth 5YN/A

INVITAE CORP / NVTA FAQ

Can you provide the ChartMill fundamental rating for INVITAE CORP?

ChartMill assigns a fundamental rating of 2 / 10 to NVTA.


What is the valuation status for NVTA stock?

ChartMill assigns a valuation rating of 1 / 10 to INVITAE CORP (NVTA). This can be considered as Overvalued.


Can you provide the profitability details for INVITAE CORP?

INVITAE CORP (NVTA) has a profitability rating of 2 / 10.


Can you provide the financial health for NVTA stock?

The financial health rating of INVITAE CORP (NVTA) is 3 / 10.